Portobello Capital
PE / VC
2010
$3 700 M
Madrid, Madrid, Spain
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Portobello Capital is the leading and the largest independent mid-market Private Equity Manager in Iberia + Italy with $3.5Bn AUM.
The firm was founded in 2010 by what is today one of the longest standing teams in the sector, a group of pioneers who joined efforts to ensure continuity to private equity funds they had been advising since the 90s.
With the most experienced and best-connected team of forty-two people, the firm invests through different vehicles and strageties in Spanish, Italian, Portuguese and, opportunistically, in European growing businesses that operate in a diverse range of industries like food, manufacturing and services - excluding financial services and real estate.
Portobello Capital takes controlling and minority stakes to boost company´s growth through levers like consolidation, professionalization, and internationalization.
PBC has executed more than 50 transactions, it is currently invested in 25 companies and its priority is to continue delivering, through a disciplined methodology, risk – adjusted returns to investors across cycles and value to all stakeholders.
Industry
Region of investment
Portobello Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
MINORITY FUND
|
Private Equity (PE)
|
Food and Beverage
Foodtech
Healthcare Services
Marketing and Advertising
Media and Entertainment
SaaS
Software
Transportation
Travel
HealthTech
|
Series B
Late Stage (Series C+)
|
Europe
|
$5-10 m
|
$150 M
|
January 2020
|
|
Portobello Secondary Fund II
|
Private Equity (PE)
|
Food and Beverage
Foodtech
Healthcare Services
Marketing and Advertising
Media and Entertainment
Robotics
SaaS
Security
Software
HealthTech
|
Series B
Late Stage (Series C+)
|
Europe
|
$5-10 m
|
$350 M
|
November 2020
|
|
Portobello Structured Partnership I
|
Private Equity (PE)
|
Food and Beverage
Foodtech
Healthcare Services
Marketing and Advertising
Media and Entertainment
Robotics
SaaS
Software
HealthTech
|
Series B
Late Stage (Series C+)
|
Europe
|
$5-10 m
|
$250 M
|
June 2022
|
